Role of the stem cell-associated intermediate filament nestin in malignant proliferation of non-small cell lung cancer

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Chen, Zhenguang ^a   Wang, Jiancheng ^a   Cai, Lie ^a   Zhong, Beilong ^a   Luo, Honghe ^a   Hao, Yuantao ^a   Yu, Weihua ^a   Wang, Binchao ^b   Su, Chunhua ^a   Lei, Yiyan ^a   Bella, Amos Ela ^a,c   Xiang, Andy Peng ^a,d   Wang, Tao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; GLYCOGEN SYNTHASE KINASE 3BETA; KI 67 ANTIGEN; NESTIN; PROTEIN KINASE B; GLYCOGEN SYNTHASE KINASE 3;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SYNTHESIS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CANCER STEM CELL; CELL PROLIFERATION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEOPLASTIC STEM CELLS; NESTIN; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84895437052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085584     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96. (Pubitemid 351521864)
2. Parkin DM, Bray F, Ferlay J, Pisani P. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
3. D'Addario G, Felip E (2009) Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20 Suppl 4: 68-70.
4. Lodish H, Berk A, Kaiser CA, Krieger M, Scott MP, et al. (2008) Molecular Cell Biology. 6th ed. New York, NY: W. H. Freeman & Company. Cancer Sections 25.1-25.5.
5. Park D, Xiang AP, Mao FF, Zhang L, Di CG, et al. (2010) Nestin is required for the proper self-renewal of neural stem cells. Stem Cells 28: 2162-2171.
6. Shimizu T, Sugawara K, Tosaka M, Imai H, Hoya K, et al. (2006) Nestin expression in vascular malformations: a novel marker for proliferate endothelium. Neurol Med Chir (Tokyo) 46: 111-117.
7. Mokry J, Cizkova D, Filip S, Ehrmann J, Osterreicher J, et al. (2004) Nestin expression by newly formed human blood vessels. Stem Cells Dev 13: 658-664. (Pubitemid 40052642)
8. Amoh Y, Yang M, Li L, Reynoso J, Bouvet M, et al. (2005) Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. Cancer Res 65: 5352-5357. (Pubitemid 40827348)
9. Sejersen T, Lendahl U (1993) Transient expression of the intermediate of the intermediate filament nestin during skeletal muscle development. J Cell Sci 106: 1291-300. (Pubitemid 24018414)
10. Li L, Mignone J, Yang M, Matic M, Penman S, et al. (2003) Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci USA 100: 9958-9961. (Pubitemid 37087050)
11. Mangiola A, Lama G, Giannitelli C, De Bonis P, Anile C, et al. (2007) Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res 13: 6970-6977. (Pubitemid 350276877)
12. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760. (Pubitemid 44949604)
13. You H, Kim YI, Im SY, Suh-Kim H, Paek SH, et al. (2005) Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma. J Neurooncol 74: 1-8. (Pubitemid 41194524)
14. Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O (1994) Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res 54: 354-356. (Pubitemid 24053166)
15. Brychtova S, Fiuraskova M, Hlobilková A, Brychta T, Hirnak J (2007) Nestin expression in cutaneous melanomas and melanocytic nevi. J Chtan Pathol 34: 370-375. (Pubitemid 46633338)
16. Li H, Cherukuri P, Li N, Cowling V, Spinella M, et al. (2007) Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 67: 501-510. (Pubitemid 46192186)
17. Kleeberger W, Bova GS, Nielsen ME, Herawi M, Chuang AY, et al. (2007) Roles for the stem cell associated intermediate filament nestin in prostate cancer migration and metastasis. Cancer Res 67: 9199-9206. (Pubitemid 47535906)
18. Ohike N, Sato M, Hisayuki T, Imataka H, Sato S, et al. (2007) Immunohistochemical analysis of Nestin and c-kit and their significance in pancreatic tumors. Pathol Int 57: 589-593. (Pubitemid 47222708)
19. Rani SB, Mahadevan A, Anilkumar SR, Raju TR, Shankar SK (2006) Expression of nestin - a stem cell associated intermediate filament in human CNS tumors. Indian J Med Res 124: 269-280. (Pubitemid 44734283)
20. Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ, et al. (2007) Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20: 102-107. (Pubitemid 44967955)
21. Chen Z, Wang T, Luo H, Lai Y, Yang X, et al. (2010) Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients. Hum Pathol 41: 737-744.
22. Thomas SK, Messam CA, Spengler BA, Biedler JL, Ross RA (2004) Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 279: 27994-27999. (Pubitemid 38900069)
23. Wei LC, Shi M, Cao R, Chen LW, Chan YS (2008) Nestin small interfering RNA (siRNA) reduces cell growth in cultured astrocytoma cells. Brain Res 1196: 103-112.
24. Sahlgren CM, Pallari HM, He T, Chou YH, Goldman RD, et al. (2006) A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death. EMBO J 25: 4808-4819. (Pubitemid 44607026)
25. Matsuda Y, Naito Z, Kawahara K, Nakazawa N, Korc M, et al. (2011) Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis. Cancer Biol Ther 11(5): 1-12.
26. Ryuge S, Sato Y, Wang GQ, Matsumoto T, Jiang SX, et al. (2011) Prognostic significance of nestin expression in resected non-small cell lung cancer. Chest 139(4): 862-869.
27. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, et al. (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2(8): 706-714. (Pubitemid 47357522)
28. Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, et al. (2007) The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2(8): 694-705. (Pubitemid 47357521)
29. Yang XH, Wu QL, Yu XB, Xu CX, Ma BF, et al. (2008) Nestin expression in different tumours and itsrelevance to malignant grade. J Clin Pathol 61: 467-473. (Pubitemid 351518229)
30. Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, et al. (2004) Nestin expression: a property of multi-lineage progenitor cells? Cell Mol Life Sci 61: 2510-2522. (Pubitemid 39586514)
31. Suzuki S, Namiki J, Shibata S, Mastuzaki Y, Okano H (2010) The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature. J Histochem Cytochem 58: 721-730.
32. Sahlgren CM, Mikhailov A, Vaittinen S, Pallari HM, Kalimo H, et al. (2003) Cdk5 regulates the organization of nestin and its association with p35. Mol Cell Biol 23: 5090-5106. (Pubitemid 36793352)
33. Yan S, Wenner CE (2001) Modulation of cyclin D1 and its signaling components by the phorbolester TPA and the tyrosine phosphatase inhibitor vanadate. Cell Physiol 186: 338-349. (Pubitemid 32147717)
34. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigation downstream. Cell 129: 1267-1274.
35. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN (1997) Transduction of interleukin-2 antiapoptotic and proliferative signals via AKT protein kinase. Proc Natl Acad Sci USA 94: 3627-3632. (Pubitemid 27180423)
36. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511. (Pubitemid 28553242)
37. Etienne-Manneville S, Hall A (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421: 753-756. (Pubitemid 36227627)
38. Turjanski AG, Vaqué JP, Gutkind JS (2007) MAP kinases and the control of nuclear events. Oncogene 26: 3240-3253. (Pubitemid 46763018)
39. Pallari HM, Eriksson JE (2006) Intermediate Filaments as Signaling Platforms. Sci STKE 2006(366): pe53.
40. Coulombe PA, Wong P (2004) Cytoplasmic intermediate filaments releaved as dynamic and multipurpose scaffolds. Nat Cell Biol 6: 699-706. (Pubitemid 39144475)
41. Yang H, He LL, Kruk P, Nicosia SV, Cheng JQ (2006) Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer 119(10): 2304-2312. (Pubitemid 44546949)
42. Breuleux M, Klopfenstein M, Stephan C, Doughty CA, Barys L, et al. (2009) Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Mol Cancer Ther 8(4): 742-753.